[27P02-276] Mechanism of action of the combination of xanthine oxidoreductase (XOR) inhibitor and inosine (ATP enhancer) effective to treat mitochondrial disease and Parkinson’s disease.
A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.